BEDFORD, Mass.--(BUSINESS WIRE)--
Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company
plans to issue its fourth-quarter 2017 financial results after the close
of the market on Wednesday, February 21, 2017 and to hold a conference
call the next day, Thursday, February 22, 2018, at 9:00 a.m. ET to
discuss its financial results, business highlights, and outlook.
The conference call can be accessed by dialing 1-855-468-0611 (toll-free
domestic) or 1-484-756-4332 (international). A live audio webcast will
be available in the "Investor
Relations" section of Anika's website, www.anikatherapeutics.com.
An accompanying slide presentation also can be accessed via the Anika
Therapeutics website. The call will be archived and accessible on the
same website shortly after its conclusion.
About Anika Therapeutics, Inc.
Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated orthopedic
medicines company based in Bedford, Massachusetts. Anika is committed to
improving the lives of patients with degenerative orthopedic diseases
and traumatic conditions with clinically meaningful therapies along the
continuum of care, from palliative pain management to regenerative
cartilage repair. The Company has over two decades of global expertise
developing, manufacturing, and commercializing more than 20 products
based on its proprietary hyaluronic
acid (HA) technology. Anika's orthopedic medicine portfolio includes ORTHOVISC®,
alleviate pain and restore joint function by replenishing depleted HA,
solid HA-based scaffold to aid cartilage repair and regeneration. For
more information about Anika, please visit www.anikatherapeutics.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180207005986/en/
For Investor Inquiries:
Sylvia Cheung, Chief Financial Officer
Source: Anika Therapeutics, Inc.
News Provided by Acquire Media